C-Path Virtual Workshop to Feature Latest Advances in Clinical Trials for T1D More than 300 Attendees and 20 Speakers Are Expected to Participate in the International Workshop, June 15-16 TUCSON, Ariz., May 2
C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board TUCSON, Ariz., May 19, 2021 — Critical Path Institute today announced the appointment of Robert M. Califf, MD, MACC, head of Cli
C-Path Announces Accelerated Data Sharing Collaboration with Tufts Medical Center FDA Grant Supports Use of Real-World Data to Generate Real-World Evidence in Neonates TUCSON, Ariz., May 12, 2021 — Criti
C-Path Appoints Quantitative Sciences Expert as New Sr. Vice President Dr. Jeff Barrett will lead C-Path’s RDCA-DAP initiative focusing on rare disease data sharing and accelerating therapy devel
C-Path Selects New Leaders of Data Science and Quantitative Medicine TUCSON, Ariz., April 26, 2021 — Critical Path Institute (C-Path) has named Amanda J. Borens, M.S., as Executive Director of Data
C-Path Opens Access to Duchenne Regulatory Science Consortium Database Database will allow sharing of individual-level data with the goal of accelerating therapy development for Duchenne muscular dystr
C-Path’s Alzheimer’s Disease Consortium Expands Data Repository New patient-level data will facilitate more efficient clinical trial design TUCSON, Ariz., April 12, 2021 — The Critical Path In
C-Path Launches Acute Kidney Injury Project with Support from FDA Project aims to develop improved predictive and detection tools for kidney injury TUCSON, March 25, 2021 — Acute kidney injury (
C-Path Names COO Kristen Swingle Interim President Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In
C-Path Program and Consortia Leaders Selected to Serve in Sr. Vice President and Vice President Roles Inish O’Doherty and Sudhir Sivakumaran will lead new programs; Stephen Joel Coons and John-Michael Sauer move into Sr. VP roles.
